HomeEverythingEducation
Equities & FundsCrypto & Digital AssetsAI & TechnologyBusiness & CorporateUS Politics & PolicyGeopolitics & Global RiskMacro, Rates & FXCommodities & EnergyEuropean Politics & MarketsAsia-PacificReal Estate & Property
Story archiveAll categories
← All Stories

Piper Sandler reiterates Tenax Therapeutics stock rating

Created at 31 May · 2:47 PM4 sources4 events
IN SHORT

Piper Sandler reiterated its stock rating for Tenax Therapeutics ahead of the company's upcoming trial. The specific rating was not disclosed.

✉Newsletter

PiQ Daily

Pick your topics. Get only what matters, on your cadence.

Who's Involved

Piper Sandler
Firm reiterating rating on Tenax Therapeutics
Tenax Therapeutics
Company with reiterated stock rating

↳ Why This Matters

Piper Sandler's reiteration of its rating on Tenax Therapeutics stock comes as the company approaches a significant upcoming trial. This action suggests the firm's continued confidence in the company's prospects.

Key facts

  • Piper Sandler reiterated its rating on Tenax Therapeutics stock.
  • The reiteration comes ahead of the company's upcoming trial.

Piper Sandler's reiteration of its rating on Tenax Therapeutics stock comes as the company approaches a significant upcoming trial. This action suggests the firm's continued confidence in the company's prospects.

Frequently asked questions

Piper Sandler reiterated its stock rating for Tenax Therapeutics.

The reiteration comes ahead of the company's upcoming trial.

No, the specific rating was not disclosed.

What Happens Next

01Tenax Therapeutics' upcoming trial.

Get the newsletter.

Pick the topics you actually care about. We'll email when there's news worth your time, on the cadence you choose. Cancel any time from your account.

Cadence
CME Headlines
  • New Product Summary: Initial Listing of Fifty-Five (55) Single Stock Futures Contracts — Effective July 27, 2026
    27 Jul · 4:32 PM
  • New Product Summary: Initial Listing of Twenty-Two (22) Micro Single Stock Futures Contracts - Effective July 27, 2026
    27 Jul · 4:11 PM
  • Initial Listing of Additional Event Contract Swaps on Pro Golf Tournaments
    9 Jul · 9:41 AM

How It Developed

1 Jun · 12:52 PM
Piper Sandler reiterated its rating on Tenax Therapeutics stock ahead of an upcoming trial.
Investing.com via PiQSuite
31 May · 2:26 PM
Piper Sandler raised Aflac's (AFL) price target, favoring insurance carriers over brokers.
Yahoo News | Finance Top Stories via PiQSuite

Sources

T1
Piper Sandler Raises Aflac (AFL) Price Target, Favors Insurance Carriers over Brokersm.piqsuite.com
T1
Piper Sandler Raises PT on The Travelers Companies (TRV) Stockm.piqsuite.com
T1
Piper Sandler Raises PT on Apollo Global Management (APO) Stockm.piqsuite.com
T1
Piper Sandler reiterates Tenax Therapeutics stock rating ahead of trialm.piqsuite.com

Related Stories

Levi Strauss raises annual outlook on steady denim demand
8 Jul · 8:17 PM
Honeywell Technologies raises 2026 profit targets after reverse stock split
8 Jul · 9:08 PM
Michael Burry Buys Flutter, DraftKings Shares on Prediction Market Threat
8 Jul · 9:51 PM
SpaceX Analyst Maintains Neutral Stance Amid Wall Street Buy Frenzy
8 Jul · 10:00 AM
JPMorgan Hires Michael Flynn to Lead New Small-Cap Banking Business
8 Jul · 3:03 PM